The active compound in the best-selling drug Ozempic markedly lowers the risk of complications from chronic kidney disease, according to a multiyear study published Friday — a finding that could ...

Ozempic is already approved to treat T2D, for cardiovascular risk reduction ... worsening kidney disease and cardiovascular death in people with T2D and CKD. …as Rybelsus cuts MACE in type ...

The Food and Drug Administration says it has seized several hundred units of fake versions of Ozempic. The drug maker Novo Nordisk told the FDA that the counterfeit 1-milligram injections were ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity ... GLP-1 drugs cut 45% lower risk of dementia. Similar findings were published in ...

The diabetes and weight loss drug semaglutide may also reverse signs of liver disease ... Ozempic and Wegovy, has become famous for treating type 2 diabetes and obesity, which are both risk ...